Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography.
about
Plasma vs heart tissue concentration in humans - literature data analysis of drugs distribution.Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution.Pharmacokinetics of [18F]trovafloxacin in healthy human subjects studied with positron emission tomography.Pharmacokinetics of [18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography.Pharmacokinetics of oral fleroxacin in male and premenopausal female volunteers.Efficacy of sparfloxacin and autoradiographic diffusion pattern of [14C]Sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection.Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humansAttenuation of gentamicin-induced nephrotoxicity in rats by fleroxacin.Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.Bactericidal Activity of Ceragenin CSA-13 in Cell Culture and in an Animal Model of Peritoneal Infection.Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.[18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans.New ultrasensitive detection technologies and techniques for use in microdosing studies.The role of positron emission tomography in pharmacokinetic analysis.
P2860
Q30909481-B4E66E9A-1D9B-44D1-936A-D50FDB363649Q31046210-C667472C-B89A-4CB9-9F1C-8CDB074541A6Q33695030-F25C0762-3684-403D-942C-0433248C9D2EQ35123048-C64F0662-7A45-4122-9B2C-748298668755Q35123376-81F98E23-55D5-40D7-86D3-AC4E027B3038Q35126785-C27A44D7-78F8-4A20-BB6C-156520F42B47Q35129720-AF922769-BC6E-4ABF-91D8-A4E8B9EBAA45Q35136503-40DC1D37-7F55-4DCE-B465-0A1589566365Q35754443-6B6372A5-EA37-4EDB-8549-F2A02968D101Q36076086-17D37C67-91F9-49C5-BDBC-D1535D33D07AQ37409468-4F7FFC26-DF01-4125-872C-FED75CAE8580Q37568411-B43BA85F-889E-4A20-B25B-DEECAD109DA0Q37810198-F17F4535-C6E2-4221-B3FD-124AAB396837Q41676775-3BD057F5-A7A9-413B-8F45-357DCB09B23E
P2860
Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Pharmacokinetics of [18F]flero ...... positron emission tomography.
@ast
Pharmacokinetics of [18F]flero ...... positron emission tomography.
@en
type
label
Pharmacokinetics of [18F]flero ...... positron emission tomography.
@ast
Pharmacokinetics of [18F]flero ...... positron emission tomography.
@en
prefLabel
Pharmacokinetics of [18F]flero ...... positron emission tomography.
@ast
Pharmacokinetics of [18F]flero ...... positron emission tomography.
@en
P2093
P2860
P356
P1476
Pharmacokinetics of [18F]flero ...... positron emission tomography.
@en
P2093
Cleeland R
Correia JA
Fischman AJ
Prosser BL
Strauss HW
P2860
P304
P356
10.1128/AAC.37.10.2144
P407
P577
1993-10-01T00:00:00Z